Journal
MOLECULAR NEUROBIOLOGY
Volume 43, Issue 1, Pages 41-66Publisher
SPRINGER
DOI: 10.1007/s12035-010-8159-8
Keywords
Nitric oxide synthase; Peripheral neuropathy; Amyotrophic lateral sclerosis; SOD1(G93A) mice; Rho kinase; Protein kinase G; Soluble guanylyl cyclase; Myosin light chain; Neurodegenerative diseases
Categories
Funding
- Ministerio de Ciencia e Innovacion [SAF2008-01415]
- Junta de Andalucia [PAI2007-CTS-02606]
- FEDER
- Mutua Madrilena Foundation, Spain
Ask authors/readers for more resources
Synapse elimination is the main factor responsible for the cognitive decline accompanying many of the neuropathological conditions affecting humans. Synaptic stripping of motoneurons is also a common hallmark of several motor pathologies. Therefore, knowledge of the molecular basis underlying this plastic process is of central interest for the development of new therapeutic tools. Recent advances from our group highlight the role of nitric oxide (NO) as a key molecule triggering synapse loss in two models of motor pathologies. De novo expression of the neuronal isoform of NO synthase (nNOS) in motoneurons commonly occurs in response to the physical injury of a motor nerve and in the course of amyotrophic lateral sclerosis. In both conditions, this event precedes synaptic withdrawal from motoneurons. Strikingly, nNOS-synthesized NO is necessary and sufficient to induce synaptic detachment from motoneurons. The mechanism involves a paracrine/retrograde action of NO on pre-synaptic structures, initiating a downstream signaling cascade that includes sequential activation of (1) soluble guanylyl cyclase, (2) cyclic guanosine monophosphate-dependent protein kinase, and (3) RhoA/Rho kinase (ROCK) signaling. Finally, ROCK activation promotes phosphorylation of regulatory myosin light chain, which leads to myosin activation and actomyosin contraction. This latter event presumably contributes to the contractile force to produce ending axon retraction. Several findings support that this mechanism may operate in the most prevalent neurodegenerative diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available